Novel Drug Delivery System
Novel Drug Delivery System
Novel Drug Delivery System
INTRODUCTION
What is NDDS?
Novel drug delivery systems
The aim :
Novel Drug Delivery System is to provide a therapeutic
amount of drug to the appropriate site in the body to
accomplish promptly and then maintain the desired drug
concentration.
For drugs to reach the targeted site with little or no side
effects.
To minimize drug degradation and loss.
Niosomes
Nanoparticles
Hydrogel
LIPOSOME
Gene Delivery
Targeted Delivery
Ocular Application
Pulmonary Application
Cancer Therapy
Antimicrobial Therapy
Arthritis
NIOSOMES
Niosomes are NDDS, in which the medication is
encapsulated in a vesicle. The vesicle is
composed of a bilayer of non-ionic surface active
agents rather than phospholipids as seen in the
case of liposomes. without incorporation of
cholesterol or other lipids.
They are similar to Liposomes and can be used
as carriers of amphiphilic and lipophilic drugs.
It is less toxic and improves the therapeutic
index of drug by restricting its action to target
cells.
STRUCTURE OF NIOSOME
COMPOSITIONS OF NIOSOMES
Sonication method
In Drug Targeting.
Neoplasia i.e. Cancer disease.
Leishmaniasis i.e. Dermal and Mucocutaneous
infections e.g. Sodium stibogluconate.
Delivery of Peptide Drugs.
Studying Immune Response.
Niosomes as Carriers for Haemoglobin.
Transdermal Drug Delivery Systems Utilizing
Niosomes.
Ophthalmic drug delivery.
Antibiotics
Niosomes as Drug Carriers
Anti-inflammatory agents
SOLID LIPID NANOPARTICLES
SLNs are colloidal carriers developed as an alternative
system to the existing traditional carriers (emulsions,
liposomes and polymeric nanoparticles).
SLN have unique properties such as small size, large
surface area, high drug loading, and the interaction of
phases at the interfaces, and are attractive for their
potential to improve performance of pharmaceuticals and
other materials
PREPARATION METHOD OF SLNS
Brain Delivery
Mucosal drug delivery
Cancer Delivery
HYDROGELS
4) Nanohydrogels
Preparation of Hydrogels
1).Wound healing
2).Colon specific drug delivery
5).Industrial applicability
6).Tissue engineering
CONCLUSIONS
Novel drug delivery system have been used in a broad
range of pharmaceutical applications. It has enhanced
drug to disease locations with short duration of time and
are now clinically accepted.
Also, it promotes targeting of particular diseased cells
within the disease site. Finally, It has exhibit reduced
toxicities and increase efficacy compared with free
convection drugs. Only time will tell which of the above
applications and speculations will prove to be successful.
However, based on the pharmaceutical applications and
available products, we can say that all the above drug
delivery system have definitely established their position
in modern delivery systems.